Liver initiation activity of norfloxacin but not nalidixic acid, pipemidic acid, and ciprofloxacin on in vivo short-term liver initiation assay in rats

Toxicology

Volumn 222, Issue 3, 2006, Pages 240-246

  Itoh, Tadashi ^a,b   Moto, Mitsuyoshi ^a,b   Takahashi, Miwa ^a,b   Sakai, Hiroki ^b   Mitsumori, Kunitoshi ^a,b  

^a TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

^b GIFU UNIVERSITY   (Japan)

Author keywords

Ciprofloxacin; Initiation activity; Nalidixic acid; Norfloxacin; Pipemidic acid; Quinolone

Indexed keywords

BUFFER; CARBON TETRACHLORIDE; CIPROFLOXACIN; ETHER; FORMALDEHYDE; GLUTATHIONE TRANSFERASE; N (2 FLUORENYL)ACETAMIDE; NALIDIXIC ACID; NORFLOXACIN; PIPEMIDIC ACID; PLACENTA ENZYME; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIETARY INTAKE; DRUG ACTIVITY; DRUG MEGADOSE; IMMUNOHISTOCHEMISTRY; LIVER SLICE; LOW DRUG DOSE; MALE; NONHUMAN; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; RAT;

2-ACETYLAMINOFLUORENE; ANIMALS; ANTI-INFECTIVE AGENTS; CARBON TETRACHLORIDE; CARCINOGENS; CIPROFLOXACIN; GLUTATHIONE TRANSFERASE; LIVER; MALE; NALIDIXIC ACID; NORFLOXACIN; PIPEMIDIC ACID; RATS; RATS, INBRED F344;

ANIMALIA;

EID: 33646098427     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2006.02.019     Document Type: Article

References (25)

1. Akasaka T., Kurosaka S., Uchida Y., Tanaka M., Sato K., and Hayakawa I. Antibacterial activities and inhibitory effects of sitafloxacin (DU-6859a) and its optical isomers against type II topoisomerases. Antimicrob. Agents Chemother. 42 (1998) 1284-1287
2. Albertini S., Chetelat A.A., Miller B., Muster W., Pujadas E., Strobel R., and Gocke E. Genotoxicity of 17 gyrase- and four mammalian topoisomerase II-poisons in prokaryotic and eukaryotic test systems. Mutagenesis 10 (1995) 343-351
3. Fort F.L. Mutagenicity of quinolone antibacterials. Drug Safety 7 (1992) 214-222
4. Fukuda M., Inomata M., Nishio K., Fukuoka K., Kanzawa F., Arioka H., Ishida T., Fukumoto H., Kurokawa H., Oka M., and Saijo N. A topoisomerase II inhibitor, NK109, induces DNA single- and double-strand breaks and apoptosis. Jpn. J. Cancer Res. 87 (1996) 1086-1091
5. Greenwood D. Activity of flumequine against Escherichia coli: in vitro comparison with nalidixic and oxolinic acids. Antimicrob. Agents Chemother. 13 (1978) 479-483
6. Herbold B.A., Brendler-Schwaab S.Y., and Ahr H.J. Ciprofloxacin: in vivo genotoxicity studies. Mutat. Res. 498 (2001) 193-205
7. Itoh T., Mitsumori K., Kawaguchi S., and Sasaki Y.F. Genotoxic potential of quinolone antimicrobials in the in vitro comet assay and micronucleus test. Mutat. Res. 603 (2006) 135-144
8. Kashida Y., Sasaki Y.F., Ohsawa K., Yokohama N., Takahashi A., Watanabe T., and Mitsumori K. Mechanistic study on flumequine hepatocarcinogenicity focusing on DNA damage in mice. Toxicol. Sci. 69 (2002) 317-321
9. Liu Q., and Wang J.C. Similarity in the catalysis of DNA breakage and rejoining by type IA and IIA DNA topoisomerases. Proc. Natl. Acad. Sci. USA 96 (1999) 881-886
10. Maura A., and Pino A. Evaluation of the DNA-damaging and mutagenic activity of oxolinic and pipemidic acids by the granuloma pouch assay. Mutagenesis 3 (1988) 397-401
11. Morrissey R.E., Eustis S., Haseman J.K., Huff J., and Bucher J.R. Toxicity and carcinogenicity studies of nalidixic acid in rodents. Drug Chem. Toxicol. 14 (1991) 45-66
12. Mukherjee A., Sen S., and Agarwal K. Ciprofloxacin: mammalian DNA topoisomerase type II poison in vivo. Mutat. Res. 301 (1993) 87-92
13. Okamura M., Sakai H., Takahashi N., Inagami A., Tsukamoto T., Yamamoto M., Shirai N., Iidaka T., Yanai T., Masegi T., and Tatematsu M. The effects of allyl alcohol-induced cell proliferation for detection of initiation activities of chemicals in rat liver. J. Toxicol. Pathol. 15 (2002) 95-102
14. Pino A., Maura A., Villa F., and Masciangelo L. Evaluation of DNA damage induced by norfloxacin in liver and kidney of adult rats and in fetal tissues after transplacental exposure. Mutat. Res. 264 (1991) 81-85
15. Sakai H., Tsukamoto T., Yamamoto M., Yanai T., Masegi T., Inada K., Nakanishi H., and Tatematsu M. Summation of initiation activities of low doses of the non-hepatocarcinogen 1,2-dimethylhydrazine in the liver after carbon tetrachloride administration. Cancer Lett. 148 (2000) 59-63
16. Sakai H., Tsukamoto T., Yamamoto M., Shirai N., Iidaka T., Yanai T., Masegi T., and Tatematsu M. Differential effects of partial hepatectomy and carbon tetrachloride administration on induction of liver cell foci in a model for detection of initiation activity. Jpn. J. Cancer Res. 92 (2001) 1018-1025
17. Sakai H., Tsukamoto T., Yamamoto M., Hirata A., Inagami A., Shirai N., Iidaka T., Yanai T., Masegi T., and Tatematsu M. Summation of initiation activities in the liver after partial hepatectomy. Cancer Lett. 176 (2002) 1-5
18. Sakai H., Tsukamoto T., Yamamoto M., Kobayashi K., Yuasa H., Imai T., Yanai T., Masegi T., and Tatematsu M. Distinction of carcinogens from mutagens by induction of liver cell foci in a model for detection of initiation activity. Cancer Lett. 188 (2002) 33-38
19. Shimada H., Itoh S., Hattori C., Tada S., and Matsuura Y. Mutagenicity of the new quinolone antibacterial agent levofloxacin. Arzneimittelforschung 43 (1992) 378-385
20. Singh A.C., Kumar M., and Jha A.M. Genotoxicity of lomefloxacin-an antibacterial drug in somatic and germ cells of Swiss albino mice in vivo. Mutat. Res. 535 (2003) 35-42
21. Tsuda H., Lee G., and Farber E. Induction of resistant hepatocytes as a new principle for a possible short-term in vivo test for carcinogens. Cancer Res. 40 (1980) 1157-1164
22. WHO, 1998. Evaluation of certain veterinary drug residues in food. Forty-eighth report of the Joint FAO/WHO Expert Committee on Food Additives. World Health Organ Technical Report Series. 879, i-vi, 1-73.
23. WHO, 2003. Evaluation of certain veterinary drug residues in food. World Health Organ Technical Report Series. 918, i-vi, 1-59, back cover.
24. WHO, 2004. Evaluation of certain veterinary drug residues in food. Sixty-second report of the Joint FAO/WHO Expert Committee on food additives. World Health Organ Technical Report Series. 925, 1-72.
25. Yamada T., Maita K., Nakamura J., Murakami M., Okuno Y., Hosokawa S., Matsuo M., and Yamada H. Carcinogenicity studies of oxolinic acid in rats and mice. Food Chem. Toxicol. 32 (1994) 397-408